These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3231041)

  • 1. [Healing of esophageal ulcer after treatment with omeprazole in a patient with scleroderma and Barrett's esophagus].
    Fiorucci S; Santucci L; Bassotti G; Pelli MA; Morelli A
    Medicina (Firenze); 1988; 8(3):306-9. PubMed ID: 3231041
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.
    Malesci A; Savarino V; Zentilin P; Belicchi M; Mela GS; Lapertosa G; Bocchia P; Ronchi G; Franceschi M
    Gastrointest Endosc; 1996 Dec; 44(6):700-5. PubMed ID: 8979061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's ulcer: the clinical significance today.
    Komorowski RA; Hogan WJ; Chausow DD
    Am J Gastroenterol; 1996 Nov; 91(11):2310-3. PubMed ID: 8931408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole and Barrett's regression: is asymptomatic good enough?
    Krueger KJ; DiPalma JA
    Am J Gastroenterol; 1997 Jan; 92(1):177-8. PubMed ID: 8995971
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic Barrett's esophagus in scleroderma.
    Sprung DJ; Gibb SP
    Am J Gastroenterol; 1985 Jul; 80(7):518-22. PubMed ID: 4014100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.
    Sampliner RE; Camargo L; Fass R
    Am J Gastroenterol; 2002 Feb; 97(2):270-2. PubMed ID: 11866260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
    Lee FI; Isaacs PE
    Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
    Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
    Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
    Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
    Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of Barrett's epithelium with omeprazole.
    Deviere J; Buset M; Dumonceau JM; Rickaert F; Cremer M
    N Engl J Med; 1989 Jun; 320(22):1497-8. PubMed ID: 2716804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Barrett's esophagus and omeprazole].
    Encinas Sotillos A; Romero Ganuza FJ; Hernández Navarrete C; Cabrerizo Puente A
    Rev Clin Esp; 1991 May; 188(9):484. PubMed ID: 1896599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Barrett esophagus in systemic sclerosis].
    Szigeti N; Fábián G; Gömöri E; Czirják L
    Orv Hetil; 2001 Apr; 142(13):671-4. PubMed ID: 11338570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow.
    Bozymski EM
    Am J Gastroenterol; 2007 May; 102(5):1128-9; author reply 1129-30. PubMed ID: 17489788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.